AFT’s governance keeps letting it down

AFT’s governance keeps letting it down
Chair David Flacks used to chair NZX’s disciplinary tribunal and governance committee. (Image: AFT)
Jenny Ruth
AFT Pharmaceuticals is a fascinating company that’s been very clever in creating new products from out-of-patent drugs and marketing them in various formats from pills to sachets for hot drinks and intravenous use.The company has an obvious runway to growth globally and founder and managing director Hartley Atkinson is very good at explaining his long-term vision for the company.However, he’s being let down by a board lacking in common sense and good judgement.Certainly, AFT’s chair, David Flacks, ought to know better seeing h...

More Markets

NZ sharemarket flat despite export growth
Markets Market close

NZ sharemarket flat despite export growth

The NZ sharemarket dipped as Fletcher Building shares fell further.

Tom Raynel 25 Jun 2025
FMA to focus on private market offers
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Pattrick Smellie 25 Jun 2025
Xero splashes $4.1b for 'step-change' US acquisition
Markets

Xero splashes $4.1b for 'step-change' US acquisition

Buying Melio gives Xero a leg-up in the crucial US SME market.

Pattrick Smellie 25 Jun 2025
Chorus broadband expansion makes priority list
Infrastructure

Chorus broadband expansion makes priority list

Chorus claims $17 billion NZ Inc gain for a $3b spend.

Pattrick Smellie 25 Jun 2025